InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hughes Steven George, Chief Medical Officer. Insider active across 1 company, notably Avidity Biosciences, Inc.. In total, 7 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €401k. History available since 6 January 2025. The latest transaction was filed on 22 October 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
2,209 shares@ US$10.1650.0% of flowCommon StockSEC:0001599901-25-000200
2,209 shares@ US$10.160.0085% mcap50.0% of flowCommon StockSEC:0001599901-25-000200:0
2,208 shares@ US$10.164.1% of flowCommon StockSEC:0001599901-25-000190:0
2,208 shares@ US$40.5816.5% of flowCommon StockSEC:0001599901-25-000190:1
9,578 shares@ US$31.059859.4% of flowCommon StockSEC:0001599901-25-000075:0
1,915 shares@ US$28.595511.5% of flowCommon StockSEC:0001599901-25-000031:0
25,000 shares0Common StockSEC:0001599901-25-000019:0
7 of 7 declarations
About Hughes Steven George
Steven George Hughes is the Chief Medical Officer at Avidity Biosciences, Inc. He oversees the company's medical and clinical initiatives, ensuring that the developed products meet safety and efficacy standards. His role is crucial for innovation and treatment development in the biotechnology field.
